6 July 2022: The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines – with the first volunteers being challenged today (Wednesday).

To facilitate south-south learning on early experiences and exchange lessons learned on computer-aided detection (CAD) and X-ray implementation and to meet global demand for support in rolling these digital tools, the Stop TB Partnership launched a global platform that brings together prospective, early, and experienced implementers debuting with two webinars in June.

RESIST-TB released its June 2022 newsletter with the latest research publications on drug-resistant TB.

The Global Plan to End TB 2023-2030 outlines the priority actions and estimated financial resources needed to end TB as a global health threat by 2030.

The health ministry is working on an initiative—called Nikshay Mitra— that will allow individuals to adopt Tuberculosis patients and look after their nutritional and medical needs in a bid to break the stigma surrounding the disease in India.

This study will demonstrate the effect of BCG revaccination in comparison to oral chemoprophylaxis on the incidence of mycobacterium tuberculosis disease in healthy household contacts, aged 6-18 years.

Chennai, Jul 4: ICMR’s National Institute for Research in Tuberculosis has initiated a study to assess the efficacy of a four-month tuberculosis treatment regimen as compared to the existing six-month regimen.

Papua New Guinea has one of the highest rates of prevalence for tuberculosis (TB) in the world, with 30,000 new cases reported every year. The situation is so alarming that the government has declared a state of emergency in some provinces.

Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

The World Health Organization (WHO), in collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria and the University of Oslo, will host a webinar on 8 July 2022 on the guidance, products and support for implementation that is available to countries to fully transition to case-based, digital surveillance systems for TB.